Recurrent ventricular tachycardia in cardiac sarcoidosis: Usefulness of fluorodeoxyglucose positron emission tomography for adequate management of corticoid therapy after placement of an implantable cardioverter defibrillator

Journal of Nuclear Cardiology

Volumn 15, Issue 2, 2008, Pages 282-285

  Casset Senon, Danielle ^a   Philippe, Laurent ^b   Renard, Jean Paul ^c   Cosnay, Pierre ^d  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b Clinique Vinci   (France)

^c CHU BRETONNEAU   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; NADOLOL; STEROID;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; CORTICOSTEROID THERAPY; DEFIBRILLATOR; DRUG DOSE REDUCTION; DRUG MEGADOSE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SARCOIDOSIS; SICK SINUS SYNDROME; SUDDEN DEATH; SYNCOPE; WHOLE BODY SCINTISCANNING;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CARDIOMYOPATHIES; COMBINED MODALITY THERAPY; ELECTRIC COUNTERSHOCK; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECURRENCE; SARCOIDOSIS; TACHYCARDIA, VENTRICULAR;

EID: 40949095390     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2008.01.006     Document Type: Article

References (13)

1. Duke C., and Rosenthal E. Sudden death caused by cardiac sarcoidosis in childhood. J Cardiovasc Electrophysiol 13 (2002) 939-942
2. Donsky A., Escobar J., Capehart J., and Roberts W.C. Heart transplantation for undiagnosed cardiac sarcoidosis. Am J Cardiol 89 (2002) 1447-1450
3. Takeda N., Yokoyama I., Hiroi Y., Sakata M., Harada T., Nakamura F., et al. Positron emission tomography predicted recovery of completed A-V nodal dysfunction in a patient with cardiac sarcoidosis. Circulation 105 (2002) 1144-1145
4. Okumura W., Iwasaki T., Toyama T., Iso T., Arai M., Oriuchi N., et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 45 (2004) 1989-1998
5. Ishimaru S., Tsujino I., Takei T., Tsukamoto E., Sakaue S., Kamigaki M., et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26 (2005) 1538-1543
6. Smedema J.P., Snoep G., van Kroonenburgh M.P.G., van Geuns R.J., Dassen W.R.M., Gorgels A.P.M., et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45 (2005) 1683-1690
7. Pandya C., Brunken R.C., Tchou P., Schoenhagen P., and Culver D.A. Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques. Eur Respir J 29 (2007) 418-422
8. Swanson N., Goddard M., McCann G., and André Ng. Sarcoidosis presenting with tachy- and brady-arrhythmias. Eurospace 9 (2007) 134-136
9. Winters S.L., Cohen M., Greenberg S., Stein B., Curwin J., Pe E., et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 18 (1991) 937-943
10. Paz H.L., McCormick D.J., Kutalek S.P., and Patchefsky A. The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosis. Chest 106 (1994) 1603-1607
11. Doughan A.R., and Williams B.R. Cardiac sarcoidosis. Heart 92 (2006) 282-288
12. Faris O.P., and Shein M.J. Government viewpoint: US Food and Drug Administration: pacemakers, IDCs, and MRI. Pacing. Clin Electrophysiol 28 (2005) 268-269
13. Nemec J. Suppression of implantable cardioverter defibrillator therapy during magnetic resonance imaging. J Cardiovasc Electrophysiol 17 (2006) 444-445